NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









4C Medical Technologies, Inc.

4C Medical Technologies, Inc.

Private
Maple Grove, MinnesotaHealthcare & Life Scienceshttps://www.4cmed.com/

Last Round

Series D

Mar 5, 2025

Total Funding Raised

$254.6M

Company Overview

4C Medical Technologies, Inc. is a medical device company that develops minimally invasive therapies for structural heart disease, specifically focusing on the treatment of mitral regurgitation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

transcatheter mitral valve replacementTMVRmitral regurgitationstructural heart diseaseheart valve replacementminimally invasive surgerycardiac medical deviceinterventional cardiologymedtechatrial fixationclinical trialheart valve implantmitral valve repair

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

4C Medical Technologies, Inc. Comps

Public and private peers based on sector, stage, and business model.

4C Medical Technologies, Inc. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

4C Medical Technologies, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DMar 5, 2025
Series CMar 31, 2022
Convertible DebtDec 22, 2020
Series BOct 2, 2019
Series ASep 10, 2018
Convertible Debt
Jul 19, 2017

Key People

Founding team and executive leadership

Saravana Kumar

Chief Executive Officer, Board Member

Executive Team

4C Medical Technologies, Inc. Investors

Notable investors and investment history

4C Medical Technologies, Inc. investors
InvestorRounds
AG Collective CapitalSeries D
MicroPort CardioFlow Medtech CorporationSeries D, Series A, Series C
Boston Scientific CorporationSeries D
Yonghua CapitalConvertible Debt
Anges QuebecConvertible Debt
Boston Scientific VenturesSeries D

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 5, 2025

    $175M round led by Boston Scientific Corporation and Cortex, Inc.

  • Mar 31, 2022

    $35.4M round led by MicroPort CardioFlow Medtech Corporation.

4C Medical Technologies, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

4C Medical Technologies, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about 4C Medical Technologies, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersMaple Grove, Minnesota
Employee Range64
Year Founded2015
Last FundingMar 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.